A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small Cell Lung Cancer and low-risk for recurrence: NVALT-8A

Trial Profile

A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small Cell Lung Cancer and low-risk for recurrence: NVALT-8A

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Jul 2016

At a glance

  • Drugs Gemcitabine (Primary) ; Pemetrexed (Primary) ; Antineoplastics; Cisplatin; Docetaxel; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms NVALT-8A
  • Most Recent Events

    • 27 Aug 2013 New source identified and integrated (Netherlands Trial Register; NTR1217).
    • 01 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top